Efficacy of Antiviral Treatment in Liver Biopsy-Proven Immune-Tolerant Chronic Hepatitis B Patients: A Retrospective Cohort Study

The optimal timing of initiating antiviral treatment for immune-tolerant (IT) patients remains unknown. We conducted this study in liver biopsy-proven IT patients to compare the long-term outcomes of untreated and treated patients suffering non-cirrhotic chronic hepatitis B (CHB). This retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Na, Yang, Nan, Ma, Wenqi, Yang, Shujuan, Hu, Chunhua, Li, Juan, Zhao, Yingren, Xu, Guanghua, He, Yingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060436/
https://www.ncbi.nlm.nih.gov/pubmed/33898489
http://dx.doi.org/10.3389/fmed.2021.655530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060436/
https://www.ncbi.nlm.nih.gov/pubmed/33898489
http://dx.doi.org/10.3389/fmed.2021.655530

Ejemplares similares